Free Trial

Maxim Group's Rating of 20/20 Biolabs on 5/11/2026

On May 11, 2026, Maxim Group updated its outlook on 20/20 Biolabs (NASDAQ:AIDX) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Maxim Group

DateCompanyAction
6/12/2026
MOO
Blue Moon Metals
Upgrade
6/12/2026
Blue Moon Metals Inc. stock logo
BMM
Blue Moon Metals
Initiated Coverage
6/10/2026
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
Boost Price Target
6/9/2026
Bragg Gaming Group Inc. stock logo
BRAG
Bragg Gaming Group
Lower Price Target
6/9/2026
Apple Inc. stock logo
AAPL
Apple
Reiterated Rating
6/8/2026
ZenaTech, Inc. stock logo
ZENA
ZenaTech
Lower Price Target
More Ratings From Maxim Group